Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Members of the European Parliament urge the EU to take action on detecting outbreaks and taking steps to end several major viral epidemics.
Gilead Sciences has filed for approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV with the European Medicines Agency.
New diagnoses of HIV in Europe and Central Asia increased by 80 percent between 2004 and 2013, from 76,000 to 136,000 diagnoses.
The European Commission has approved ViiV Healthcare’s integrase inhibitor Tivicay to treat HIV-positive adults and adolescents older than 12....
Despite a decade of gains in fighting the spread of HIV among intravenous drug users in the European Union (EU), there are reasons to worry ab...
Michel Sidibe, executive director of UNAIDS, says that about 86 percent of people with HIV/AIDS around the globe who are on treatment are...
About 3,000 people with HIV and cancer protested in the streets of New Delhi against a planned free trade agreement between India and the Euro...
A new Free Trade Agreement (FTA) between India and the European Union (EU) could limit access to cheap Indian generic drugs, PlusNews reports.
A deficit of health care workers within developing countries can partially be blamed on the West, Reuters reports.
Reyataz boosted with low-dose Norvir has been approved as a first-line protease inhibitor option in the European Union, according to AIDSmap.
In August 2008, the U.S. is expected to implement a Web-based pretravel authorization process for foreigners entering the country, the Associa...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.